
A three year postdoctoral position is available in my group, investigating plant centromere structure, function and evolution @plantsci jobs.cam.ac.uk/job/51488/

We're the Dray lab. We like chromosomes and study DNA repair and recombination at UTHSCSA. Tweets are a group effort, sharing science we like.

A three year postdoctoral position is available in my group, investigating plant centromere structure, function and evolution @plantsci jobs.cam.ac.uk/job/51488/

It is going to be a great conference, join us! There is still time to register!
Update on ##Recombination25 Conference! 🚨 📅RD & PS Deadline: 13th March 2025. DON'T MISS OUT! 🌟Grants are available for students, postdocs & junior investigators!🌟 For more details, visit bit.ly/41v8IuK or email Felicity at 📧felicity@fusion-conferences.com

Hello friends! Just a reminder that we have made the move to the blue place 🦋 and I will delete this account at the end of the month. Please migrate with us!

Just like everyone else, moving to the bluer place. Yes, it took a while, because we're slow to catch up 😀. Find us there, friends!

Just published📢 Our new forum article on Fc-optimized checkpoint antibodies for cancer therapy. New to immunotherapy and antibody engineering? This one’s for you! Co-authored with Alan Korman. @TrendsMolecMed #CancerImmunotherapy #FcEngineering sciencedirect.com/science/ar…

Thrilled to have @maria_spies visit @uthscsa today! Looking fwd to one of her superb seminars :)

Free scientific illustrations for biologists! 😍 @NIH has released a library of 500+ free scientific illustrations to create figures, presentations, and illustrations! all freely available in the public domain. Retweet and spread the message! bioart.niaid.nih.gov/

Collaborative paper alerts! The 1st on PDL1 role in DDR is being proofed rn so I'll post next week. 2nd is this beauty from the @PatrickSungLab "Distinct roles of the two BRCA2 DNA binding domains in DNA damage repair and replication fork preservation" biorxiv.org/content/10.1101/…

2nd, AI is getting better everyday. We should be clear that articles need to be written by people and based on real data now, as soon enough there won't be a call to be made. There are way too many new paper submissions for all of them to be real. Anyone else feels like me? 3/3

First of all, the nerves! I am not on payroll, reviewers are not on payroll. Why are we to waste time we don't have on a machine written manuscript? As far as I am aware, AI is not accepted by main publishers (yes, small title from one of the big publishing groups).

Hey science peeps! I get a ton of requests to edit manuscripts. Accepted one, obviously written by AI. Ran it, came back 100% AI,0% human, 5 different detectors. Today, nasty email from editor in chief telling me they don't accept my rejection, and to send it 4 review 1/3

Last day of Entrepreneurs Bootcamp at @Geekdom San Antonio. So much info, so much networking, and such great mentorship! I loved meeting this cohort and we will see each other again. Now, who want to hear my elevator pitch?! 😁

Hello, DNA repair Tweeter peeps! We have a fab cryo-EM facility but they cannot take just any project I throw at them (time constraints + scientific choices). Who is your go to cryo-EM facility? Please contact me directly if you're a structural core with some time or interest!

Polyploidy is bad as it promotes drug resistance + is linked w/ poor outcomes. Thankfully, the combination of alisertib and Aurkin A, an Aurora A TPX2 site inhibitor, ↘️ polyploidy and ↗️ apoptosis. Basic science at the service of drug development, stay tuned for translation! 3/3

Not going to lie, this one took some serious effort! Very enjoyable collaboration with the Mahadevan lab @UTHealthSAMDA @UTHSAResearch where we find that Alisertib, an ATP site inhibitor of Aurora A kinase, induces cell cycle dysregulation and polyploidy in DLBL 2/3

New paper alert! Aurkin-A, a TPX2-aurora a small molecule inhibitor disrupts Alisertib-induced polyploidy in aggressive diffuse large B cell lymphoma published today 1/3 authors.elsevier.com/sd/arti…